Sustained-Release Bupropion for Smoking Cessation in African Americans: A Randomized Controlled Trial
- Ahluwalia, J. S.
Publication date
January 2002
DOIAbstract
Abstract available at publisher's web site.http://dx.doi.org/10.1001/jama.288.4.46
Abstract available at publisher's web site.http://dx.doi.org/10.1001/jama.288.4.46
Among people trying to quit smoking, bupropion may be more beneficial for non‐Hispanic white than fo...
BACKGROUND: Cigarette smoking continues to be the leading cause of preventable morbidity and mortali...
Objective: To evaluate bupropion SR for smoking cessation in physicians and nurses. Methods: This do...
Bupropion SR is approved for the treatment of tobacco dependence in adult smokers. Bupropion SR is a...
BackgroundThis is the first study to examine predictors of successful cessation in African American ...
BackgroundAfrican Americans are at risk of inadequate adherence to smoking cessation treatment, yet ...
Abstract Background African Americans experience significant tobacco-related health disparities desp...
Objective. To evaluate efficacy of bupropion sustained-release for smoking cessation compared with p...
Study Overview Objective. To determine the effectiveness of sustained-release bupropion for smoking ...
The advent of bupropion hydrochloride sustained release (Zyban) has heralded a major change in the o...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not antidepressants...
Bupropion is a first-line pharmacological aid for smoking cessation; however, no clinical trials hav...
Background Tobacco smoking is associated with chronic obstructive pulmonary disease (COPD) in more t...
Bupropion and varenicline are effective, first-line prescription-only pharmacotherapies for smoking ...
Background: Studies undertaken in academic settings have shown that bupropion hydrochloride can doub...
Among people trying to quit smoking, bupropion may be more beneficial for non‐Hispanic white than fo...
BACKGROUND: Cigarette smoking continues to be the leading cause of preventable morbidity and mortali...
Objective: To evaluate bupropion SR for smoking cessation in physicians and nurses. Methods: This do...
Bupropion SR is approved for the treatment of tobacco dependence in adult smokers. Bupropion SR is a...
BackgroundThis is the first study to examine predictors of successful cessation in African American ...
BackgroundAfrican Americans are at risk of inadequate adherence to smoking cessation treatment, yet ...
Abstract Background African Americans experience significant tobacco-related health disparities desp...
Objective. To evaluate efficacy of bupropion sustained-release for smoking cessation compared with p...
Study Overview Objective. To determine the effectiveness of sustained-release bupropion for smoking ...
The advent of bupropion hydrochloride sustained release (Zyban) has heralded a major change in the o...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not antidepressants...
Bupropion is a first-line pharmacological aid for smoking cessation; however, no clinical trials hav...
Background Tobacco smoking is associated with chronic obstructive pulmonary disease (COPD) in more t...
Bupropion and varenicline are effective, first-line prescription-only pharmacotherapies for smoking ...
Background: Studies undertaken in academic settings have shown that bupropion hydrochloride can doub...
Among people trying to quit smoking, bupropion may be more beneficial for non‐Hispanic white than fo...
BACKGROUND: Cigarette smoking continues to be the leading cause of preventable morbidity and mortali...
Objective: To evaluate bupropion SR for smoking cessation in physicians and nurses. Methods: This do...
Add to ORKG